Loading...
Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer.
Price, A Yellowlees, A Keerie, C Russell, S Gilligan, D Snee, M Skailes, G Hatton, M Erridge, S
Price, A
Yellowlees, A
Keerie, C
Russell, S
Gilligan, D
Snee, M
Skailes, G
Hatton, M
Erridge, S
Citations
Altmetric:
Abstract
Preclinical and phase I data suggest gemcitabine to be a potent radiosensitiser. This multicentre study addressed whether the addition of low dose gemcitabine to radical radiotherapy improved 2 year event-free survival in patients with medically inoperable stages I-II non-small cell lung cancer.
Description
Date
2012-09
Publisher
Collections
Keywords
Type
Article
Citation
Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer. 2012, 77 (3):532-6 Lung Cancer